Ascendis Pharma A/S (NASDAQ:ASND) released topline data on Monday from a trial that included 84 children with achondroplasia, a genetic disorder that causes dwarfism and disproportionate short stature ...
SAN RAFAEL (CBS SF) -- A San Rafael pharmaceutical company is on its way to helping children with dwarfism grow taller. BioMarin Pharmaceuticals Inc. scientists announced Wednesday new data that they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback